EXPERT REPORT: THE SITUS REQUIREMENT FOR CONNECTICUT R&D TAX CREDITS: DECONSTRUCTING “RESEARCH CONDUCTED IN CONNECTICUT”
I. Executive Summary: The Nexus Requirement for Connecticut R&D Credits
The definition of “Research Conducted in Connecticut” establishes a strict geographic limitation requiring that R&D expenses must be physically paid or incurred within the state to qualify for tax credits. This territorial mandate applies to both the 20% Incremental (RC) and the Non-Incremental (RDC) credits, fundamentally modifying the federal definition of Qualified Research Expenses (QREs) for Connecticut tax purposes.
This mandate, embedded in the statutory language governing the corporate tax credits (Connecticut General Statutes, Chapter 208), transforms the compliance burden for multi-state taxpayers. It necessitates meticulous, activity-based sourcing methodologies, demanding that specific Qualified Research Expense (QRE) components—wages, supplies, and contract research—must be allocated to the state based on the physical location where the underlying research activities take place, supported by rigorous documentation demanded by the Department of Revenue Services (DRS). The rigorous application of the situs rule ensures that the state’s fiscal incentives are targeted exclusively toward research and experimentation (R&E) that demonstrably benefits Connecticut’s economy.
A. Overview of Connecticut’s Dual Credit Structure
Connecticut utilizes a dual mechanism to incentivize R&D investment for corporations subject to the Corporation Business Tax (Chapter 208). Taxpayers must calculate eligibility under both structures and select the greater benefit, provided they meet all statutory criteria.1
- The Research and Experimental Expenditures Tax Credit (RC Credit): Codified under CGS § 12-217j, this credit is incremental, designed to reward companies that are increasing their R&D spending year-over-year. The credit rate is 20% of the excess of current year CT-sourced R&D expenses over the preceding tax year’s base amount.1
- The Research and Development Expenses Tax Credit (RDC Credit): Codified under CGS § 12-217n, this credit is non-incremental and volume-based, offering a percentage of the total qualified R&D expenses incurred in Connecticut during the income year.1 This credit is particularly beneficial for companies with stable, high-volume R&D spending or those facing an economic downturn where year-over-year increases are challenging.
II. Foundational Statutory and Regulatory Definitions
Connecticut’s framework builds directly upon federal tax law but introduces specific limitations and expansions that must be precisely understood for compliance.
A. Adoption and Modification of IRC § 174 and IRC § 41
Connecticut’s definition of “Research and development expenses” is intrinsically linked to the Internal Revenue Code (IRC), but with a critical fixed reference date.3
- The Fixed Reference Date: The statutory definitions refer to research or experimental expenditures deductible under Section 174 of the Internal Revenue Code of 1986, and basic research payments under Section 41, as in effect on May 28, 1993.4 This historical fixed-date reference is a vital element of state tax policy. By freezing the definition to the 1993 framework, the Connecticut General Assembly strategically preserves the scope of eligible activities and expenditures, effectively shielding the state credit from subsequent restrictive changes in federal law, such as the mandatory five-year amortization of Section 174 expenses implemented in later decades. This provides long-term predictability and stability for taxpayers claiming the credit.4
- The Four-Part Federal Test: Any research activity generating qualified expenses must inherently meet the four core requirements defined under federal law (IRC § 41(d)), which Connecticut adopts: (1) the expense must be eligible for amortization under IRC § 174, (2) the research must be technological in nature, (3) it must be intended to gain new technical knowledge useful in developing a new or improved product, process, or technique, and (4) it must involve a process of experimentation aimed at developing a new or improved function, performance, reliability, or quality.6
- Basic Research Payments: The definition also includes basic research payments as defined under IRC § 41, such as payments made to qualifying non-profit institutions for original investigations advancing scientific knowledge, provided they are not otherwise deducted under IRC § 174. Such basic research must also be conducted within the state.7
B. Connecticut’s Specific Inclusion of Patent Costs
While the federal credit focuses primarily on in-house research expenses (wages, supplies) and contract research, Connecticut explicitly expands the scope of eligible R&D expenditures to include “Costs of obtaining a patent, such as attorneys’ fees expended in making and perfecting a patent application”.3
This explicit inclusion is a key statutory differentiation. It recognizes that legal fees related to securing intellectual property (IP) protection are a necessary cost incident to the development of a commercial product. Certain guidance from practitioners suggests these costs, often contested under stricter federal interpretations, are fully includible at 100% to the extent they are incurred within Connecticut.9 This legislative decision to embrace a broader scope of R&D activity is intended to directly incentivize IP development and legal work to be sited within the state.
C. The “Non-Funded” Requirement
To be recognized as a qualified expense, the expenditure or payment must not be funded by an outside grant, contract, or other mechanism from a person or governmental entity other than the taxpayer, consistent with the rules outlined in IRC § 41(d)(4)(H).4
However, a critical statutory exception exists for multi-entity structures: if the funding party is included in the taxpayer’s combined unitary tax return filed under CGS § 12-222, the expenditure is still considered “non-funded” and qualifies for the credit. This provision allows for internal research contracts between related entities within a combined reporting group without compromising the credit eligibility.4
III. Deconstructing the “Research Conducted in Connecticut” Situs Rule
The fundamental principle governing credit calculation in Connecticut is the territorial limit, which mandates that the R&D activity itself must be sited within the state.4
A. The Statutory Mandate and Allocation Principle
The law clearly requires the expenses to be “paid or incurred for such research and experimentation and basic research conducted in this state“.4 This strict situs requirement contrasts sharply with standard multi-state corporate apportionment formulas, which often rely on sales or property factors. For the R&D credit, Connecticut requires a granular tracing of activity, focusing on where the research services are physically performed or where the resources are physically consumed.
B. DRS Compliance and Required Documentation Methodology
The Connecticut Department of Revenue Services (DRS) guidance, lacking a specific formulaic regulation (such as an administrative ruling or policy statement defining multi-state allocation percentages), instead places the burden on the taxpayer to define and defend a rigorous allocation methodology. This requirement is enforced through the mandated attachments to the claim forms (Form CT-1120 RDC or Form CT-1120RC).
Taxpayers are required to submit comprehensive documentation, including:
- A full and complete description of the nature of the research projects conducted during the income year and the location(s) where the research is conducted.11
- A full and complete description of the methods used to obtain the total expenditures and payments for research and experimentation and basic research conducted in Connecticut.11
- A detailed description of each source of information used to compute the tax credit, including the methods and calculations of expense allocation, if any.8
This strict requirement to submit the allocation methodology directly with the return demonstrates that the DRS relies on this documentation as the primary basis for assessing compliance. This effectively mandates the adoption of physical activity tracing principles, forcing multi-state taxpayers to certify that their allocation method is logical and defensible against the foundational federal situs rules. Non-compliant or high-level allocations (e.g., using general sales apportionment ratios) risk immediate scrutiny and are an obvious flag during a subsequent R&D audit, where physical verification of activity—such as review of time sheets and laboratory usage logs—would be demanded.
IV. Detailed Situs Allocation Mechanics by QRE Category
The allocation methodology must address each component of QREs individually, confirming the physical location where the qualified research occurs.
A. Wages for Qualified Services
Wages paid for qualified services represent the largest component of R&D expenditures.12 For multi-state employers, determining the Connecticut-situs wage base involves two specific hurdles: the physical activity test and the statutory exclusion.
- Physical Activity Tracing: For employees performing qualified research (engaging in research, direct supervision, or direct support 12) in multiple states, the credit-eligible portion of their wages must be allocated strictly based on the verifiable percentage of time spent performing those qualified services physically within Connecticut. Detailed time-tracking records are essential to prove the performance situs.
- Statutory Link to Apportionment: Connecticut introduces a unique complexity by defining the R&D wage base by reference to the total wages assigned to Connecticut under the standard corporate apportionment statute, CGS § 12-218.5 This overlay creates a mandatory two-step audit trail: first, the taxpayer must justify that the wage is sourced to CT under the general payroll factor rules (which may be based on control/direction); second, the taxpayer must prove, hour by hour, that the specific qualified research service was physically rendered in Connecticut.
- Exclusion of Highly Compensated Executives: Connecticut explicitly excludes wages paid to the ten most highly-compensated executives of the taxpayer, or the combined group, from the calculation of the Connecticut wage base for the R&D credit.5 This legislative exclusion ensures that the credit benefit is concentrated on the operational R&D teams directly involved in the experimentation process, rather than being inflated by high-cost, senior management compensation, thereby aligning the incentive more closely with direct technical output.
B. Supplies and Computer Lease/Use Expenses
- Supplies Situs: Expenses for supplies—tangible property consumed and not retained for general use 12—are sourced to Connecticut based on the physical location where they are consumed or used during the qualified research activity.3
- Computer Use Situs: Amounts paid or incurred to another person for the right to use computers in the conduct of qualified research are sourced based on the physical location where the computer resources are utilized. This rule is highly relevant for cloud computing costs or high-performance clusters dedicated to R&D activities located at a Connecticut facility.12
C. Contract Research Expenses
Contract research expenses, which are capped at 65% of the amount paid to an unrelated third party to conduct qualified research 12, are subject to the same strict territorial rule.
- Situs Rule: The expense is sourced to Connecticut based on the physical location where the contracted research services were performed by the third-party researcher.10
- Documentation Requirement: The taxpayer must exercise due diligence and secure documentation from the vendor certifying the location of performance to substantiate the Connecticut allocation. If a contract researcher operates nationally, only the documented portion conducted in CT qualifies (and then is subjected to the 65% inclusion rate).
The situs rules summarized below demonstrate the unique allocations required for Connecticut compliance.
Table 1: Connecticut QRE Components and Situs Rules
| QRE Component (IRC Basis) | CT Statutory Basis | Inclusion Rate | Situs Rule for Connecticut Allocation |
| In-House Wages for QRE Services | CGS § 12-217n; CGS § 12-218 | 100% | Allocated strictly based on physical services performed in Connecticut, excluding the top ten highly compensated executives. |
| Supplies Consumed in Research | CGS § 12-217n | 100% | Allocated based on the location where the supplies are physically consumed or used in qualified research. |
| Contract Research Payments | CGS § 12-217n | 65% | Allocated based on the physical location where the contracted research activities are conducted by the third party. |
| Patent Costs (Attorney Fees) | CGS § 12-217n (explicit inclusion) | 100% | Allocated based on where the legal/technical services incident to patent preparation are performed/incurred. |
V. Mechanics of the Dual Credit Regime
The dual credit system requires taxpayers to calculate and compare both the incremental (RC) and non-incremental (RDC) options annually to maximize their benefit.
A. Research and Experimental (RC) Credit (CGS § 12-217j)
This incremental credit is calculated using a single-year base, which is simpler than the federal four-year base calculation. The purpose of this credit is to directly reward year-over-year increases in R&D investment within the state.2
- Credit Rate: 20% of the incremental increase.1
- Base Calculation: The base amount is the total Connecticut-sourced R&E expenditures from the immediately preceding income year.1
- Formula: Credit = 20% $\times$ (Current Year CT QREs – Prior Year CT QREs). The excess amount is calculated only if the current year QREs exceed the base amount.1
B. Research and Development (RDC) Credit (CGS § 12-217n)
The non-incremental credit applies a rate against the total current-year CT R&D expenses, making it the preferred option for companies with stagnant, declining, or already high R&D expenditures that do not generate significant incremental growth.
- Qualified Small Business (QSB) Rate: A Qualified Small Business (defined as having gross income for the previous income year of $100 million or less, excluding income from related party transactions used to artificially meet the test 3) is eligible for a flat 6% credit on their total Connecticut R&D expenses.1
- Tiered Rates (Non-QSBs): For corporations not meeting the QSB definition, the credit is calculated using a progressive tiered structure, where the benefit increases significantly with higher levels of Connecticut R&D spending.1
Table 2: RDC Non-Incremental Credit Tiered Rates (CGS § 12-217n)
| Total Connecticut R&D Spending | Credit Percentage | Credit Calculation |
| $\le$ $50 million | 1% | 1% of total CT R&D spending |
| > $50 million but $\le$ $100 million | Tiered 2% | $500,000 + 2% of amount over $50 million |
| > $100 million but $\le$ $200 million | Tiered 4% | $1,500,000 + 4% of amount over $100 million |
| > $200 million | Tiered 6% | $5,500,000 + 6% of amount over $200 million |
Companies headquartered in an Enterprise Zone (EZ) with revenues over $3 billion and more than 2,500 employees may elect the greater of (1) 3.5% of their R&D spending or (2) the percentage calculated via the tiered schedule.7
VI. Illustrative Example: Application of Situs Rules and Credit Calculation
This example demonstrates the essential preliminary step of situs allocation for a multi-state taxpayer, followed by the comparative credit calculation.
A. Scenario Setup and Situs Allocation
A large manufacturing company, InnovateCorp (a Non-QSB), operates a main factory in New York but maintains a dedicated R&D laboratory and testing facility in Hartford, Connecticut.
| Metric | Prior Year (Year 1) | Current Year (Year 2) |
| Taxpayer Type | Non-QSB (Gross Revenue $150M) | Non-QSB (Gross Revenue $160M) |
| Total National R&D Expenses | $10,000,000 | $15,000,000 |
| Total CT-Sourced QREs (Base) | $6,000,000 | TBD (Situs Calculation Required) |
In Year 2, InnovateCorp incurred $15,000,000 in total national QREs. The company’s internal time-tracking and facility utilization records provide the following allocation data:
| QRE Component | National Expense | CT Allocation Factor (Physical Situs) | CT-Sourced QREs (Year 2) |
| 1. Wages (Excluding Execs) | $10,000,000 | 70% of time spent physically in CT lab | $7,000,000 |
| 2. Supplies Used | $3,000,000 | 80% consumed in CT testing facility | $2,400,000 |
| 3. Contract Research (65%) | $2,000,000 | 60% of contracted work performed in CT facility | $2,000,000 $\times$ 60% $\times$ 65% = $780,000 |
| Total CT-Sourced QREs (Year 2) | $15,000,000 | – | $10,180,000 |
B. Step 2: Calculation of Incremental (RC) Credit (CGS § 12-217j)
The calculation determines the credit based on the growth of CT-specific R&D activity.
- Current Year CT QREs: $10,180,000
- Prior Year CT QREs (Base): $6,000,000
- Excess (Incremental) QREs: $10,180,000 – $6,000,000 = $4,180,000
- RC Credit: $4,180,000 $\times$ 20% = $836,000
C. Step 3: Calculation of Non-Incremental (RDC) Credit (CGS § 12-217n)
Since InnovateCorp’s gross revenue exceeds $100 million, it is not a QSB and must use the tiered schedule.
- Current Year CT QREs: $10,180,000
- Tier Applicable: The QREs are greater than $0 but $\le$ $50 million (the 1% rate applies).1
- RDC Credit: $10,180,000 $\times$ 1% = $101,800
D. Conclusion of Example
In this instance, InnovateCorp would elect the RC Incremental Credit of $836,000. The analysis confirms that for a corporation experiencing significant growth in its Connecticut R&D activities, the 20% incremental rate offers a substantially greater tax benefit than the entry-level tiers of the non-incremental rate.
VII. Limitations, Carryforwards, and Refundability
The calculated credit amounts are subject to various limitations regarding their annual utilization and disposition.
A. Credit Utilization Limitations
The maximum amount of R&D credit (whether RC or RDC) that may be taken in any income year is statutorily restricted against the Corporation Business Tax liability. Generally, the total credit allowed is limited to the greater of (a) 50% of the taxpayer’s tax liability (determined without regard to credits), or (b) the lesser of 200% of the credit otherwise allowed for the income year and 90% of the taxpayer’s tax liability.14 Other guidance suggests a limit of 50.01% of the tax due.8
A mandatory rule dictates the order of credit application: no credit allowed under CGS § 12-217n (RDC) shall be taken in any income year until the full amount of all allowable credits carried forward from any prior income year have been fully utilized, commencing with the earliest prior year.4
B. Carryforward Provisions
Unused R&D credits maintain value through generous carryforward provisions:
- 15-Year Carryforward: For credits earned in tax years beginning on or after January 1, 2021, any unused credits may be carried forward for up to 15 years.15
- Unlimited Carryforward: Credits earned in income years prior to 2021 are generally permitted an unlimited carryforward period.15
C. Exchange of Credit for Refund (Qualified Small Businesses)
Connecticut provides a potent financial incentive for startup and early-stage development companies, particularly those in the biotech sector, by offering a cash refund for unused credits.9 This mechanism is not merely a tax offset but functions as an economic development tool that provides non-dilutive capital to companies that are in tax-loss positions.
- Strict Eligibility: This exchange provision is strictly limited to Qualified Small Businesses (QSBs) whose gross income does not exceed $70 million in the previous year (a threshold lower than the $100 million required for the 6% RDC rate).15 Furthermore, the QSB must have no current tax liability under the Corporation Business Tax.16
- Refund Calculation: An eligible QSB may elect to exchange the credit for a refund equal to 65% of the credit’s value.15
- Limitations and Procedure: The annual exchange is capped at $1,500,000 per tax year.1 The application requires the filing of Form CT-1120 XCH, Application for Exchange of Research and Development or Research and Experimental Expenditures Tax Credits by a Qualified Small Business, separately from the primary corporate tax return (Form CT-1120 or CT-1120CU). Required supporting schedules, including the R&D credit form (CT-1120RC or CT-1120 RDC) and all allocation documentation, must be attached to the exchange application.16
VIII. Conclusion: Compliance Demands Physical Activity Tracing
Connecticut’s R&D tax credit regime is explicitly designed to maximize economic impact within the state by strictly enforcing a territorial requirement. The phrase “Research Conducted in Connecticut” serves as a precise statutory nexus rule, demanding that taxpayers allocate expenses based on the physical situs of the research activity, rather than relying on general economic presence or simplified apportionment methods.
Compliance requires meticulous documentation beyond standard accounting records. To withstand audit scrutiny, taxpayers must:
- Establish a clear audit trail demonstrating that the research activity satisfies the four-part federal definition (IRC § 41(d)), as interpreted under the fixed 1993 statutory reference.
- Develop and implement a granular, defensible allocation methodology that physically traces the time of qualified employees (net of the top ten executives), the consumption of supplies, and the execution of contracted research services to specific locations within Connecticut.
- Submit a detailed description of this methodology with the corporate tax return, acknowledging the DRS’s reliance on this self-certification.
For multi-state corporations, the strategic determination of the optimal credit (the high-rate 20% incremental RC credit versus the high-volume RDC credit) is secondary to the foundational requirement of accurate, physical situs allocation. The robust refundability provision for eligible small businesses, offering immediate cash flow in exchange for a future tax asset, significantly strengthens the policy goal of anchoring high-growth, innovative companies within the Connecticut jurisdiction.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










